(Q45242200)
Statements
1 reference
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia (English)
1 reference
Samuel G Siris
1 reference
J Alexander Bodkin
1 reference
Paul C Bermanzohn
1 reference
John Hennen
1 reference
Jonathan O Cole
1 reference
1 February 2005
1 reference
1 reference
162
1 reference
2
1 reference
388-390
1 reference
Identifiers
1 reference
1 reference